United States· US:0121-0977_7e29cb53-c401-49b0-9b47-209601f7ec55
Cefotan
A cefotetan product containing cefotetan disodium, registered in United States by PAI Holdings, LLC dba PAI Pharma.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFOTETAN DISODIUM
- Manufacturer
- PAI Holdings, LLC dba PAI Pharma
- Country
- United States (US)
- ATC code
- J01DC05
- ATC class
- Cefotetan
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110121-0977-10
- ndc11012109771010 VIAL in 1 TRAY (0121-0977-10) / 20 mL in 1 VIAL (0121-0977-55)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for cefotetan.
Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefotetan · interactions on record
25 records
- 25 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01DC05
Cefotetan, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19d2d130-63df-49d6-91f1-eb138cab4980 GET /v1/drugs/19d2d130-63df-49d6-91f1-eb138cab4980?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "CEFOTETAN DISODIUM",
"productndc": "0121-0977",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/20mL",
"application_number": "NDA050588",
"marketing_category": "NDA"
}See everything about cefotetan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.